rs3916

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000017.4(ACADS):​c.*21G>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.256 in 1,599,860 control chromosomes in the GnomAD database, including 54,823 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.22 ( 4370 hom., cov: 33)
Exomes 𝑓: 0.26 ( 50453 hom. )

Consequence

ACADS
NM_000017.4 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -1.11

Publications

45 publications found
Variant links:
Genes affected
ACADS (HGNC:90): (acyl-CoA dehydrogenase short chain) This gene encodes a tetrameric mitochondrial flavoprotein, which is a member of the acyl-CoA dehydrogenase family. This enzyme catalyzes the initial step of the mitochondrial fatty acid beta-oxidation pathway. Mutations in this gene have been associated with short-chain acyl-CoA dehydrogenase (SCAD) deficiency. Alternative splicing results in two variants which encode different isoforms. [provided by RefSeq, Oct 2014]
ACADS Gene-Disease associations (from GenCC):
  • short chain acyl-CoA dehydrogenase deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia, Orphanet, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 12-120739469-G-C is Benign according to our data. Variant chr12-120739469-G-C is described in ClinVar as Benign. ClinVar VariationId is 254692.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.308 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ACADSNM_000017.4 linkc.*21G>C 3_prime_UTR_variant Exon 10 of 10 ENST00000242592.9 NP_000008.1 P16219E5KSD5
ACADSNM_001302554.2 linkc.*21G>C 3_prime_UTR_variant Exon 10 of 10 NP_001289483.1 P16219E9PE82B4DUH1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ACADSENST00000242592.9 linkc.*21G>C 3_prime_UTR_variant Exon 10 of 10 1 NM_000017.4 ENSP00000242592.4 P16219
ACADSENST00000411593.2 linkc.*21G>C 3_prime_UTR_variant Exon 10 of 10 2 ENSP00000401045.2 E9PE82
ENSG00000255946ENST00000724268.1 linkn.305-9181C>G intron_variant Intron 1 of 1

Frequencies

GnomAD3 genomes
AF:
0.219
AC:
33368
AN:
152120
Hom.:
4364
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0906
Gnomad AMI
AF:
0.286
Gnomad AMR
AF:
0.315
Gnomad ASJ
AF:
0.331
Gnomad EAS
AF:
0.144
Gnomad SAS
AF:
0.282
Gnomad FIN
AF:
0.270
Gnomad MID
AF:
0.351
Gnomad NFE
AF:
0.261
Gnomad OTH
AF:
0.251
GnomAD2 exomes
AF:
0.270
AC:
61810
AN:
229280
AF XY:
0.270
show subpopulations
Gnomad AFR exome
AF:
0.0840
Gnomad AMR exome
AF:
0.368
Gnomad ASJ exome
AF:
0.330
Gnomad EAS exome
AF:
0.148
Gnomad FIN exome
AF:
0.269
Gnomad NFE exome
AF:
0.267
Gnomad OTH exome
AF:
0.297
GnomAD4 exome
AF:
0.260
AC:
376486
AN:
1447622
Hom.:
50453
Cov.:
35
AF XY:
0.262
AC XY:
188755
AN XY:
719628
show subpopulations
African (AFR)
AF:
0.0837
AC:
2789
AN:
33328
American (AMR)
AF:
0.363
AC:
16077
AN:
44332
Ashkenazi Jewish (ASJ)
AF:
0.338
AC:
8801
AN:
26022
East Asian (EAS)
AF:
0.142
AC:
5612
AN:
39488
South Asian (SAS)
AF:
0.298
AC:
25661
AN:
85980
European-Finnish (FIN)
AF:
0.264
AC:
11911
AN:
45178
Middle Eastern (MID)
AF:
0.365
AC:
1676
AN:
4596
European-Non Finnish (NFE)
AF:
0.260
AC:
287931
AN:
1108804
Other (OTH)
AF:
0.268
AC:
16028
AN:
59894
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
15531
31061
46592
62122
77653
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9632
19264
28896
38528
48160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.219
AC:
33376
AN:
152238
Hom.:
4370
Cov.:
33
AF XY:
0.226
AC XY:
16849
AN XY:
74444
show subpopulations
African (AFR)
AF:
0.0903
AC:
3750
AN:
41532
American (AMR)
AF:
0.315
AC:
4821
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.331
AC:
1148
AN:
3468
East Asian (EAS)
AF:
0.144
AC:
746
AN:
5180
South Asian (SAS)
AF:
0.282
AC:
1362
AN:
4832
European-Finnish (FIN)
AF:
0.270
AC:
2864
AN:
10610
Middle Eastern (MID)
AF:
0.347
AC:
102
AN:
294
European-Non Finnish (NFE)
AF:
0.261
AC:
17777
AN:
67994
Other (OTH)
AF:
0.258
AC:
545
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1335
2670
4004
5339
6674
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
364
728
1092
1456
1820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.200
Hom.:
701
Bravo
AF:
0.216
Asia WGS
AF:
0.250
AC:
865
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Deficiency of butyryl-CoA dehydrogenase Benign:2
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
0.77
DANN
Benign
0.67
PhyloP100
-1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3916; hg19: chr12-121177272; COSMIC: COSV54368611; COSMIC: COSV54368611; API